J. Smalberg

发表

Budd-Chiari Syndrome and Portal Vein Thrombosis: Etiology and Treatment

J. Smalberg, 2012 .

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.

D. Valla, L. Arends, H. Janssen, 2012, Blood.

Long‐term follow‐up of patients with portal vein thrombosis and myeloproliferative neoplasms

F. Leebeek, J. Smalberg, J. Hoekstra, 2011, Journal of thrombosis and haemostasis : JTH.

Superimposed coagulopathic conditions in cirrhosis: infection and endogenous heparinoids, renal failure, and endothelial dysfunction.

F. Leebeek, J. Smalberg, 2009, Clinics in liver disease.

Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis

P. Pattynama, H. Janssen, F. Leebeek, 2008, Thrombosis and Haemostasis.

Prothrombotic disorders in abdominal vein thrombosis.

H. Janssen, F. Leebeek, J. Smalberg, 2012, The Netherlands journal of medicine.

Absence of the JAK2 V617F mutation in patients with arterial thrombosis without overt myeloproliferative disease

F. Leebeek, M. D. de Maat, F. Leebeek, 2008, Journal of thrombosis and haemostasis : JTH.

Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome.

H. Janssen, F. Leebeek, P. Valk, 2006, Haematologica.

Hypercoagulability and Hypofibrinolysis and Risk of Deep Vein Thrombosis and Splanchnic Vein Thrombosis: Similarities and Differences

F. Leebeek, M. Kruip, M. D. de Maat, 2011, Arteriosclerosis, thrombosis, and vascular biology.

The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis.

D. Valla, J. Trebicka, H. Janssen, 2011, Blood.

Fibrinogen γ’ and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis

D. Valla, J. Trebicka, H. Janssen, 2013, Thrombosis and Haemostasis.